Nutex Health (NASDAQ:NUTX) Downgraded by Wall Street Zen to Buy

Wall Street Zen downgraded shares of Nutex Health (NASDAQ:NUTX) from a strong-buy rating to a buy rating in a research report report published on Thursday.

NUTX has been the topic of several other research reports. Maxim Group boosted their target price on Nutex Health from $100.00 to $225.00 and gave the stock a “buy” rating in a report on Tuesday. Benchmark upped their price target on Nutex Health from $150.00 to $300.00 and gave the company a “buy” rating in a report on Thursday, May 15th.

Nutex Health Stock Performance

Shares of NASDAQ NUTX opened at $161.86 on Thursday. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. The firm’s 50-day moving average price is $111.47 and its two-hundred day moving average price is $65.26. Nutex Health has a 52-week low of $4.16 and a 52-week high of $184.28. The stock has a market capitalization of $900.91 million, a P/E ratio of -17.24 and a beta of -0.10.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $2.71. The company had revenue of $211.79 million for the quarter, compared to analysts’ expectations of $81.09 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Insiders Place Their Bets

In related news, CFO Jon Christian Bates purchased 1,000 shares of the stock in a transaction dated Tuesday, April 8th. The shares were acquired at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the acquisition, the chief financial officer now directly owns 4,888 shares in the company, valued at approximately $399,887.28. The trade was a 25.72% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 38.52% of the company’s stock.

Institutional Investors Weigh In On Nutex Health

Several institutional investors and hedge funds have recently modified their holdings of NUTX. Topline Capital Management LLC acquired a new stake in shares of Nutex Health in the 4th quarter valued at $5,690,000. American Century Companies Inc. acquired a new position in shares of Nutex Health during the fourth quarter valued at about $1,362,000. Ancora Advisors LLC acquired a new position in shares of Nutex Health during the fourth quarter valued at about $1,334,000. Drive Wealth Management LLC acquired a new position in shares of Nutex Health during the fourth quarter valued at about $1,122,000. Finally, Essex Investment Management Co. LLC raised its position in shares of Nutex Health by 45.4% during the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company’s stock valued at $3,353,000 after buying an additional 33,024 shares during the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.